Proceeding contribution from Iqbal Mohamed (Independent (affiliation)) in the House of Commons on Tuesday, 30 June 2026. It occurred during Estimates day on Department of Health and Social Care.
Department of Health and Social Care
Will the hon. Gentleman to comment on the fact that the NHS pays 10 times the manufacturing costs for over 80% of the licensed medicines that we buy? How is that underpaying?
Secondary information
- Type
- Proceeding contribution
- Reference
- 788 c853
- Session
- 2026-27
- Chamber / Committee
- House of Commons chamber
- Subjects
- Cost effectiveness Drugs NHS Manufacturing industries Public expenditure Standards Trade agreements National Institute for Health and Care Excellence USA Impact assessments Life sciences
- Link
- View this Proceeding contribution on hansard.parliament.uk
Librarians' tools
- Timestamp
- 2026-07-01 14:14:51 +0100
- URI
- http://hansard.intranet.data.parliament.uk/Commons/2026-06-30/26063042000115
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2026-06-30/26063042000115
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2026-06-30/26063042000115